NCT06769100

Brief Summary

An acute bout of resistance exercise stimulates muscle protein synthesis (MPS) rates for up to 24-48 hours, supporting muscle growth and repair. To optimize the anabolic effects of resistance exercise, the provision of dietary amino acids (i.e., proteins) is essential. Dietary protein intake provides the body with necessary amounts of essential and non-essential amino acids, which represent the building blocks for muscle proteins, enhancing anabolic muscle growth. The ingestion of dietary protein, such as whey protein, is well established to stimulate an increase in the rate of protein synthesis in skeletal muscle following resistance exercise. Research has demonstrated a dose-dependent relationship between protein intake and MPS rate, with 25 grams being the optimal dose to maximally stimulate MPS rates in younger adults with excess protein oxidized as a fuel source. Determining whether this maximally stimulated MPS response can be further heightened during post-exercise recovery using non-protein dietary factors is yet to be explored. Recently, it has been shown that novel orally ingested ketone body supplements can stimulate MPS rates in younger adults at rest. Ketone bodies (β-OHB) are lipid- derived molecules normally produced under conditions of glucose deprivation (i.e., fasting/starvation, or a low carbohydrate 'ketogenic' diet). However, these orally ingested ketone supplements rapidly increase blood ketone levels without the need for dietary restriction6. In vitro research showed that the combination of leucine and ketone bodies stimulated a 2-fold increase in MPS, compared to the leucine group alone, indicating synergistic effects of protein and ketone bodies on MPS. However, the effect of ketone supplementation, with and without dietary protein co-ingestion, on MPS rate during post-exercise recovery is yet to be investigated. If ketone bodies can amplify the anabolic response to dietary protein, they may provide a novel approach to maximizing muscle adaptation during post-exercise recovery. Therefore, the purpose of this study is to evaluate the effects of ketone monoester intake on postprandial muscle protein synthesis rates when consumed alone and when co-ingested with an optimal dose (25 g) of whey protein during recovery after resistance exercise compared to 1) an optimal dose of whey protein (25 g), and 2) a control flavored water. It is hypothesized that muscle protein synthesis rates will be stimulated following the ingestion of the ketone body beverage. Further, muscle protein synthesis rates will be further enhanced when the ketone-containing beverage and an optimal dose are taken together.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 10, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

January 10, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2026

Completed
Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

1.1 years

First QC Date

January 6, 2025

Last Update Submit

March 19, 2026

Conditions

Keywords

KetosisRegulation of Muscle Protein SynthesisResistance ExercisePost-Exercise RecoveryWhey Protein

Outcome Measures

Primary Outcomes (1)

  • Myofibrillar fractional synthesis rate

    Quantification of changes in basal myofibrillar fractional synthetic rate (%/hour) in the rested and exercised limbs.

    0 - 5 hours in the postprandial period.

Secondary Outcomes (14)

  • Time-course data for plasma enrichments (in moles percent excess) of L-[ring-2H5]-phenylalanine

    Baseline, 3 hours pre-prandial, and 5 hours into the postprandial period.

  • Incremental area under the curve for total amino acid concentration

    3 hours pre-prandial to 5 hours postprandial

  • Time-course data for total amino acid concentration

    Baseline, 3 hours pre-prandial, and 5 hours into the postprandial period.

  • Incremental area under the curve for essential amino acid concentration

    3 hours pre-prandial to 5 hours postprandial

  • Time-course data for essential amino acid concentration

    Baseline, 3 hours pre-prandial, and 5 hours into the postprandial period.

  • +9 more secondary outcomes

Study Arms (4)

Ketone Monoester (KET)

EXPERIMENTAL

Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight).

Dietary Supplement: Ketone Monoester (KET)Other: Resistance exercise

Ketone Monoester + Whey Protein (KET+PRO)

EXPERIMENTAL

Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and 25g of whey protein.

Dietary Supplement: Ketone Monoester + Whey Protein (KET+PRO)Other: Resistance exercise

Whey Protein (PRO)

EXPERIMENTAL

25g of whey protein.

Dietary Supplement: Whey Protein (PRO)Other: Resistance exercise

Placebo drink (CON)

PLACEBO COMPARATOR

Flavoured water.

Dietary Supplement: Flavour matched placebo (CON)Other: Resistance exercise

Interventions

Ketone Monoester (KET)DIETARY_SUPPLEMENT

\- Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight). The ketone brand name: delta G Oxford Ketone Ester

Ketone Monoester (KET)

* Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) * 25g Whey Protein * L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)

Ketone Monoester + Whey Protein (KET+PRO)
Whey Protein (PRO)DIETARY_SUPPLEMENT

* 25g Whey Protein * L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)

Whey Protein (PRO)

\- Flavoured water (non-caloric bitter + citrus flavours)

Placebo drink (CON)

\- 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.

Ketone Monoester (KET)Ketone Monoester + Whey Protein (KET+PRO)Placebo drink (CON)Whey Protein (PRO)

Eligibility Criteria

Age18 Years - 40 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsCis males and Cis females
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adult female or male participants who are 18-40 years of age (inclusive) BMI \>18.5 and \<30.0 kg/m2
  • Moderately active (i.e., ≥ 1 session of lower-body weightlifting /week for the previous 2 months).

You may not qualify if:

  • Be willing to entirely avoid alcohol consumption 48hr prior to the experimental test day.
  • Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, be able to understand and read the questionnaires, and carry out all study-related procedures.
  • Females who are lactating or pregnant
  • Females using third-generation oral contraceptives (including: Desogen®, Ortho-Cept, Ortho-Cyclen, Ortho Tri-Cyclen) as these are known to affect protein metabolism in females.
  • Individuals with metabolic disorders including: Type I or Type II diabetes
  • Individuals with a history of thrombosis / cardiovascular disease
  • Individuals who use of anticoagulants
  • Individuals with musculoskeletal / orthopedic disorders
  • Individuals with knee injuries (i.e., ACL injuries).
  • Individuals who have used tobacco products within the last 6 months
  • Individuals with a history of neuromuscular problems
  • Chronic usage of medications known to modulate skeletal muscle metabolism (i.e. corticosteroids, hormone replacement therapy (HRT), and over-the-counter supplements including creatine monohydrate) in the last 6 months.
  • Individuals with allergies to milk proteins (whey or casein).
  • Individuals with lactose intolerance
  • Individuals with Phenylketonuria (PKU)
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McGill University

Montreal, Quebec, H2W 1S4, Canada

Location

MeSH Terms

Conditions

Ketosis

Interventions

Whey ProteinsResistance Training

Condition Hierarchy (Ancestors)

AcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Milk ProteinsAnimal Proteins, DietaryDietary ProteinsProteinsAmino Acids, Peptides, and ProteinsWheyMilkDairy ProductsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Tyler Churchward-Venne, PhD

    Department of Kinesiology and Physical Education, McGill University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants, Investigators and Outcome Accessors will be blinded to the intervention and control drinks. The drinks will be flavor matched and provided in an opaque bottle. An individual not involved with the study data collection, analysis and interpretation will be designated as a study blinder and randomizer.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 6, 2025

First Posted

January 10, 2025

Study Start

January 10, 2025

Primary Completion

March 2, 2026

Study Completion

March 2, 2026

Last Updated

March 23, 2026

Record last verified: 2026-03

Locations